We are Xcited to announce XponentL's participation in Neo4j's GraphSummit September 5th in NYC! Engage with knowledge graph pioneer Tom Plasterer as he moderates the Life Sciences panel joined by experts from Johnson & Johnson, Bristol Myers Squibb, Novartis who will delve into real world Graph use cases. This panel will focus on: • Supply chain optimization • Pharmaceutical development • Examining case studies that show us the role of graph databases in • Accelerating drug discovery • Optimizing clinical trials • Ensuring adherence to stringent regulatory requirements. This is an incredible opportunity to gain insights, ask questions, and network with leading professionals. 🗓️ September 5th, 9:00am – 5:00pm 📍 Nasdaq 151 W 42nd St., New York City 🔗 https://lnkd.in/dx7cwskz Looking forward to a lively and insightful discussion, and, most of all, seeing you there! #Neo4j #Neo4jGraphSummit #PanelDiscussion #IndustryTrends #Networking #Innovation
XponentL Data’s Post
More Relevant Posts
-
Collaboration is a key component of medical innovation. We proudly partner with health research organizations and pharmaceutical companies who share our core values and are dedicated to driving science and technology forward. Discover how we can work together to transform healthcare: https://lnkd.in/eXqkjzGr #clinicalphenotyping #research #clinicalstudies #PGx #pharmacogenomics
To view or add a comment, sign in
-
M.Pharmacy (Pharmaceutics) | Regulatory Affairs, Pharmacovigilance & Clinical Research enthusiast | Certified in ICH-GCP
I had the privilege of attending the international conference at SMBT College of Pharmacy on 05 &06th of january, where the theme centered around the Integration of Artificial Intelligence and Traditional Medicine in Drug Design. It was truly inspiring to witness groundbreaking discussions and presentations on this frontier of pharmaceutical innovation. From exploring AI-driven drug discovery to leveraging traditional medicine's insights, the conference provided invaluable insights into the future of healthcare. Grateful to the organizers and speakers for such a enlightening experience! #PharmaceuticalInnovation #AIIntegration #SMBTConference"
To view or add a comment, sign in
-
We’re passionate about helping pharmaceutical companies better understand patient experiences and enhance product differentiation through prospective real-world generation strategies. Find out more in this Xtalks Spotlight Interview with Pack Health’s Kelly Brassil, PhD. The discussion dives into current challenges in real-world evidence generation, how prospective data collection and patient experience studies can generate deep insights, and strategies for building an evidence generation strategy customized to your needs. Check out the Xtalks Spotlight Interview: https://lnkd.in/gPYTdd4V
To view or add a comment, sign in
-
Ashutosh Kumar Shukla (MK Shukla), Founder & Director at Drug Chemistry Research Centre||In-silico Drug Design & Discovery || Research Collaborator
Important for beginners to learn Computer Aided Drug Design and Discovery methods.
Ashutosh Kumar Shukla (MK Shukla), Founder & Director at Drug Chemistry Research Centre||In-silico Drug Design & Discovery || Research Collaborator
Join us on April 15th, 2024, for a groundbreaking one-day national conference on Computer-Aided Drug Design and Discovery. Explore the latest advancements in computational methods driving pharmaceutical innovation. Network with leading experts in the field and gain insights into cutting-edge research. Don't miss this opportunity to delve into the future of drug development. Register now to secure your place in shaping tomorrow's healthcare landscape. Registration link https://lnkd.in/ggARUsXk Website: https://dcrc.co.in/ For more information: WhatsApp at 8269823155 or 8077799897 #nationalconference #insilicodrugdesign #drugdiscovery
To view or add a comment, sign in
-
📢 [Point of View] A Dose of Digital: Can Pharma Make Digital Therapeutics a Healthy Business? A new point of view by Ipsos explores the complex world of digital therapeutics (DTx). As pharmaceutical companies increasingly strive to integrate digital therapeutics into their strategies, they encounter challenges in navigating regulatory uncertainty and slow adoption rates. The authors, Francine Fram and Svetlana Gogolina, share a 5-stage framework for developing resilient and scalable digital therapeutics businesses. Read the full article here: https://lnkd.in/eHDEWY-K #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy
To view or add a comment, sign in
-
📢 [Point of View] A Dose of Digital: Can Pharma Make Digital Therapeutics a Healthy Business? A new point of view by Ipsos explores the complex world of digital therapeutics (DTx). As pharmaceutical companies increasingly strive to integrate digital therapeutics into their strategies, they encounter challenges in navigating regulatory uncertainty and slow adoption rates. The authors, Francine Fram and Svetlana Gogolina, share a 5-stage framework for developing resilient and scalable digital therapeutics businesses. Read the full article here: https://lnkd.in/emEh8-PT #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy
To view or add a comment, sign in
-
🌟 Join Circuit Clinical for an enlightening webinar series on enhancing participant representation in research through community-based clinical trials! 💡 The first webinar in the series explores Circuit Clinical’s Community Research Network and the impact of community #healthcare on accelerating drug development and medical innovation. 🎤 Featured speakers will delve into: ➔ The significance of community-based research in the pharmaceutical landscape ➔ How community-based research sites differ from traditional models ➔ Challenges and considerations for pharmaceutical sponsors and CROs ➔ Factors to weigh when selecting a community research site 🔗 REGISTER HERE: https://buff.ly/3uP4XEq ⭐ Featured speakers: Alaina Anderson, MBA Elizabeth Seyfert Laura Warwick #DrugDevelopment #ClinicalResearch #PatientRecruitment #ClinicalSites #PatientParticipation
To view or add a comment, sign in
-
🌟 Exploring Drug Efficacy with Quantitative Surveys 🌟 Dive into our latest carousel to see how leveraging quantitative market research for clinicians' and patients' feedback on drug efficacy is crucial in shaping effective treatments. From pinpointing patient responses to optimizing drug formulations, this research provides the insights necessary for groundbreaking advancements in healthcare. Swipe through to uncover the power of data in pharmaceutical research! 🔗 Learn more about our research methods and their impact at www.grgonline.com #DrugDevelopment #PatientCare #HealthcareData #ClinicalResearch #PharmaInnovation #GRGHealth
To view or add a comment, sign in
-
Watch the panel discussion on ‘Advances in Drug Discovery & Development 2024’ by Technology Networks in conversation with Clarivate experts - Matthew Arnold and Mike Ward - along with Hong I. Wan, CEO and Founder of Tallac Therapeutics, in the Clarivate Companies to Watch report. Gain insights on: ➡️ The history of ADC development, highlighting the challenges pharma companies face across the development and commercialization lifecycle and what they should consider when acquiring and using ADCs. ➡️ Current clinical activity and dealmaking in the ADC space, reflecting the growing maturity of ADC technologies. ➡️ The regulatory environment around ADCs and how it differs across key markets. ➡️ The challenges pharma companies face in developing linker technology. ➡️ What the next generation of ADCs will look like and their potential to address unmet therapeutic needs. View here: https://lnkd.in/eKMKKHWM #DrugDiscovery #Pharmaceuticals #ADCs #Regulatory #HealthcareLeadership
To view or add a comment, sign in
-
Check out our latest paper on DTx. We talk about the challenges but more importantly how you can build a solid foundation for success! #digitaltherapeutics #healthcare #digital
📢 [Point of View] A Dose of Digital: Can Pharma Make Digital Therapeutics a Healthy Business? A new point of view by Ipsos explores the complex world of digital therapeutics (DTx). As pharmaceutical companies increasingly strive to integrate digital therapeutics into their strategies, they encounter challenges in navigating regulatory uncertainty and slow adoption rates. The authors, Francine Fram and Svetlana Gogolina, share a 5-stage framework for developing resilient and scalable digital therapeutics businesses. Read the full article here: https://lnkd.in/emEh8-PT #DigitalTherapeutics #DTx #HealthcareInnovation #PharmaStrategy
To view or add a comment, sign in
4,424 followers